Endoluten
Endoluten is a Khavinson peptide bioregulator derived from the neuroendocrine (pineal-hypothalamic) complex. Proposed to restore circadian rhythmicity, support melatonin biosynthesis, and modulate neuroendocrine aging. Used alongside Epithalon.
Community Rating
No ratings yet
Compound Profile
Endoluten
Key Data
Research reference only
Research Focus
Preclinical data
⚠ Research & Educational Use Only. Endoluten is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Proposed to support pineal gland peptide biosynthesis — complement to Epithalon's telomerase approach to pineal aging
- May restore circadian rhythm gene expression in aged pineal and hypothalamic tissue
- Targeted at neuroendocrine aging — the age-related decline in the coordinated hormonal response to light-dark cycles
- Endoluten is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Proposed to support pineal gland peptide biosynthesis — complement to Epithalon's telomerase approach to pineal aging
- May restore circadian rhythm gene expression in aged pineal and hypothalamic tissue
- Targeted at neuroendocrine aging — the age-related decline in the coordinated hormonal response to light-dark cycles
- Used in anti-aging longevity stacks alongside Epithalon as a complementary pineal bioregulator
In Plain English
Simple summaryEndoluten is a synthetic polypeptide from the Khavinson bioregulator series targeted specifically at the pineal gland -- it's the pineal bioregulator counterpart to Epithalon (the tetrapeptide from the same research group). While Epithalon is a defined tetrapeptide (Ala-Glu-Asp-Gly), Endoluten is described as a complex of polypeptides from pineal gland tissue rather than a single defined sequence, placing it closer to the Thymalin (thymus extract) category than the fully defined synthetic Khavinson peptides. It is proposed to restore melatonin secretion, circadian rhythm regulation, and the anti-aging functions attributed to the pineal gland. The pineal gland's declining function is the conceptual basis for Epithalon, Pinealon, and Endoluten.
- Proposed to support pineal gland peptide biosynthesis — complement to Epithalon's telomerase approach to pineal aging
- May restore circadian rhythm gene expression in aged pineal and hypothalamic tissue
- Targeted at neuroendocrine aging — the age-related decline in the coordinated hormonal response to light-dark cycles
The full scientific detail, mechanisms, citations, and dosing data, follows below.
What is Endoluten?
Tap any underlined term for an instant definition.
Endoluten is a peptide bioregulator developed within Professor Vladimir Khavinson's research program, derived from the neuroendocrine complex (pineal gland and hypothalamus) of young animals. Unlike Epithalon, which is a defined tetrapeptide (Ala-Glu-Asp-Gly), Endoluten is a more complex preparation containing a mixture of short regulatory peptides from neuroendocrine tissue, similar in approach to thymic peptide preparations like Thymalin.
The neuroendocrine system is considered a primary regulator of aging pace in Khavinson's theoretical framework. As the pineal gland and hypothalamic nuclei age, their ability to maintain coordinated hormonal signaling — particularly melatonin synthesis, circadian rhythm entrainment, and hypothalamic-pituitary axis coordination — declines. This contributes to the desynchronization of hormonal rhythms (sleep-wake, cortisol, sex hormone cycles) observed in aging.
Endoluten is proposed to deliver short regulatory peptides that can restore gene expression in the pineal and hypothalamic tissue to a more youthful pattern, complementing the telomere biology approach of Epithalon (which activates telomerase in pineal tissue via its tetrapeptide sequence).
Clinical studies from the Khavinson group (published in journals including the Bulletin of Experimental Biology and Medicine, Russian Gerontology, and Advances in Gerontology) have reported improvements in sleep quality, hormonal rhythm markers, and cognitive function scores in elderly subjects treated with neuroendocrine bioregulator protocols. These studies were primarily conducted in Russian clinical research settings and have not been extensively replicated internationally.
By the Numbers
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Endoluten. See all Immune System peptides for comparison.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Khavinson bioregulator protocol (neuroendocrine bioregulation):
Oral: 10 mg twice daily × 30 days SC injection (intensive): 1-5 mcg/kg/day × 10-14 days Frequency: 1-2 courses per year for aging research protocols
Often combined with: Epithalon (Ala-Glu-Asp-Gly) for comprehensive pineal-focused anti-aging protocols
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Oral capsule or SC injection. Part of the Khavinson Institute bioregulator system targeting the neuroendocrine-immune axis in aging.
What the research doesn't show
Endoluten's complex, undefined peptide nature makes it harder to study rigorously than single-sequence peptides. The melatonin restoration claims are interesting given melatonin's documented decline with age, but whether polypeptide supplementation reliably restores pineal secretory capacity is not established. Supplementing melatonin directly is a far simpler and better-evidenced approach for anyone primarily interested in circadian and sleep effects.
Medical Expert Videos
Physicians, researchers, and pharmacologists explain Endoluten, covering mechanisms of action, clinical context, and study findings.
Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.
The Bottom Line
Endoluten has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: proposed to support pineal gland peptide biosynthesis — complement to epithalon's telomerase approach to pineal aging.
The most commonly reported side effect in research subjects is minimal adverse effects reported in clinical usage within the khavinson research program. It is a research chemical, not approved for human use.
Frequently Asked Questions
Explore Further
Quick Reference
How It Compares
Epithalon is the better-defined single-sequence alternative with more published mechanistic data. Pinealon (Ala-Glu-Asp) is another synthetic tripeptide for pineal targets. Melatonin itself is far better studied for circadian regulation and sleep. Among the three pineal peptide research options, Epithalon has the most published data and is the most clearly defined compound.
Compare Endoluten side-by-sideResearch Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.